首页> 美国卫生研究院文献>British Journal of Cancer >Expression and subcellular localization of cyclin D1 protein in epithelial ovarian tumour cells
【2h】

Expression and subcellular localization of cyclin D1 protein in epithelial ovarian tumour cells

机译:cyclin D1蛋白在卵巢上皮性肿瘤细胞中的表达及亚细胞定位

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The expression of cyclin D1 protein in tumour sections from 81 patients with epithelial ovarian cancer was analysed using immunohistochemistry. The tumours that overexpressed cyclin D1 in more than 10% of neoplastic cells were considered positive. Thus overexpression of cyclin D1 was observed in 72/81 (89%) of the cases examined. Protein was detected in both the nucleus and the cytoplasm in 24/81 (30%) and localized exclusively in the cytoplasm in 48/81 (59%) of the tumours. Cyclin D1 was overexpressed in both borderline and invasive tumours. There was no association between protein overexpression and tumour stage and differentiation. Furthermore, no correlation between cyclin D1 expression and clinical outcome was observed. However, in tumours overexpressing cyclin D1 (n = 72), the proportion displaying exclusively cytoplasmic localization of protein was higher in those with serous compared with non-serous histology (P = 0.004, odds ratio 4.8, 95% confidence interval 1.4–19.1). Western analysis using a monoclonal antibody to cyclin D1 identified a 36 kDa protein in homogenates from seven tumours displaying cytoplasmic only and one tumour demonstrating both nuclear and cytoplasmic immunostaining. Using restriction fragment length polymorphism polymerase chain reaction and PCR-multiplex analysis, amplification of the cyclin D1 gene (CCNDI) was detected in 1/29 of the tumours demonstrating overexpression of cyclin D1 protein. We conclude that deregulation of CCND1 expression leading to both cytoplasmic and nuclear protein localization is a frequent event in ovarian cancer and occurs mainly in the absence of gene amplification. © 1999 Cancer Research Campaign
机译:应用免疫组织化学分析81例卵巢上皮性癌患者肿瘤组织中cyclin D1蛋白的表达。在超过10%的肿瘤细胞中过度表达细胞周期蛋白D1的肿瘤被认为是阳性的。因此,在72/81(89%)的检查病例中观察到细胞周期蛋白D1的过表达。在24/81(30%)的细胞核和细胞质中均检测到蛋白质,仅在48/81(59%)的肿瘤细胞质中定位。细胞周期蛋白D1在边缘和浸润性肿瘤中均过表达。蛋白过表达与肿瘤分期和分化之间没有关联。此外,未观察到细胞周期蛋白D1表达与临床结果之间的相关性。但是,在过度表达细胞周期蛋白D1的肿瘤中(n = 72),与非浆液性组织学相比,浆液性蛋白中仅显示细胞质定位蛋白的比例更高(P = 0.004,比值比4.8,95%置信区间1.4-19.1) 。使用针对细胞周期蛋白D1的单克隆抗体进行的Western分析在来自7个仅显示胞质的肿瘤和1个同时显示核和细胞质免疫染色的肿瘤的匀浆中鉴定出36 kDa蛋白。使用限制性片段长度多态性聚合酶链反应和PCR多重分析,在1/29的肿瘤中检测到细胞周期蛋白D1基因(CCNDI)的扩增,表明细胞周期蛋白D1蛋白过表达。我们得出结论,导致细胞质和核蛋白定位的CCND1表达失控是卵巢癌中的常见事件,主要发生在基因扩增缺失的情况下。 ©1999癌症研究运动

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号